Private Healthcare Australia’s latest research into specialist fees is, on its face, a health-policy story. But for the broader insurance market, it is also a warning about risk accumulation: delayed treatment, worsening morbidity, pressure on household finances and structural strain on the public system that ultimately feeds into higher claims costs and policyholder dissatisfaction across multiple lines.
The national survey of more than 4,000 Australians – including 2,300 recently referred to a specialist – finds almost one-in-three have delayed or cancelled specialist care due to cost in the past three years, rising to one-in-two families with multiple children managing long-term health conditions. That is a significant cohort of people who are, in effect, self-insuring short term and likely to present later with more advanced conditions.
For health insurers, that translates into greater claims severity when members eventually access care. For life and income protection carriers, it raises the probability of longer disability durations and more complex return-to-work pathways. For workers’ compensation and group schemes, it points to higher lost-time risk where early specialist intervention is critical.
The report documents a pattern of “bill shock” and opaque charging in community-based specialist care – from psychiatrists and cardiologists through to surgeons – with one-in-two patients not knowing the fee before the appointment, 38% receiving an unexpected bill and 55% getting a bill larger than expected. A further 29% were charged illegal ‘administration’ or ‘booking’ fees and almost one-in-five asked to pay non‑refundable deposits upfront.
That opacity is more than a consumer rights issue. For commercial insurers and brokers, it makes it harder to forecast cost trends, price group health and benefits programs, and demonstrate value to corporate clients who are already grappling with premium inflation. It also raises reputational risk where employer-sponsored cover is perceived as a gateway to an unpredictable and stressful billing experience.
“These are not luxury services people are skipping," said Private Healthcare Australia CEO Dr Rachel David. For underwriters, that line goes to the heart of adverse selection risk. When medically necessary care is deferred on cost grounds, claims do not disappear; they are deferred, often at higher eventual cost.
The report found median in‑hospital specialist gap fees have climbed 22% since 2022, from $222 to $270, with some patients outside hospital being asked to pay up to $1000 upfront for a single appointment. In the ACT, patients face average out‑of‑pocket costs of $605 per hospital service – $335 above the national average – underscoring stark geographic inequity.
For insurers with national portfolios, these regional cost differentials complicate pricing, reserving and network strategy. Products marketed as “Australia‑wide” are effectively exposed to different cost curves by jurisdiction, and customer experience can diverge sharply between metro and regional areas. With 61% of rural Australians saying they cannot get a timely appointment due to specialist shortages, regional members and workers are at higher risk of delayed diagnoses and avoidable disease progression.
The research also highlighted a shift in patient behaviour within the mixed public–private system. Between 2019 and 2024, GP attendances rose 4%, while initial specialist consultations fell 8%, suggesting more patients are being “funnelled back” to GPs or into public hospital waiting lists rather than receiving timely specialist treatment. That pattern ultimately increases pressure on already stretched public hospitals and emergency departments, where Dr David notes “more people are presenting…with more severe illness”.
For insurers, that dynamic blurs the line between public and private risk. When privately insured members opt out of specialist care due to affordability concerns and end up in the public system for serious episodes, it fuels debate around the value of private cover and the sustainability of the current funding split – a live concern for any long‑term product strategy.
There are clear financial-stability implications at the household level as well. Early withdrawals from superannuation for medical treatment almost doubled in two years to reach $1.04 billion in 2023–24. From an insurance and retirement incomes perspective, that represents a transfer of risk from the health system to individuals’ future selves, and potentially to life and longevity insurers down the track.
Private Healthcare Australia’s proposed reform package – stronger consumer protections to curb surprise billing, better fee transparency tools for GPs, measures to address regional specialist shortages and broader scope‑of‑practice reforms – is framed as a health-access agenda. But it would also help restore predictability to the claims environment and rebuild trust in the value proposition of private insurance.
For commercial insurers and brokers operating in the health, life, income protection and group benefits space, the report is both a data point and a call to action: to push for clearer billing practices, support employer clients with navigation and education tools, and factor an affordability-driven care gap into risk models and product design.
“If we don’t act, Australians will continue to forgo care, people will get sicker, and the health system will face higher long-term costs from preventable illness." said Dr David. For the wider insurance industry, those higher long‑term costs are not an abstract policy concern – they are tomorrow’s claims.
